newsfilter
← Latest News
PR Newswire·

Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program

Conference Call Today at 4:30 p.m. ETSAN DIEGO, Aug. 13, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (NASDAQ:AEMD), a clinical-stage medical therapeutic company, today announced financial results